Hepatitis C virus infection among drug addicts in Italy

Journal of Medical Virology

Volumn 84, Issue 10, 2012, Pages 1608-1612

  Stroffolini, T ^a   D'Egidio, P F ^b   Aceti, A ^c   Filippini, P ^d   Puoti, M ^e   Leonardi, C ^f   Almasio, P L ^g   Pieri, Maria Chiara ^h   Balestra, Roberta ⁱ   Lucchini, Alfio ^j   Riglietta, Marco ^k   Marino, Vincenzo ^l   Bignamini, Emanuele ^m   Somaini, Lorenzo ⁿ   Lovaste, Raffaele ^o   Nava, Felice ^p   D'Egidio, Pietro Fausto ^q   Fasciani, Paola ^r   Cesarini, Fernando ^s   Leonardi, Claudio ^s   Meini, Milo ^t   Ruffa, Francesco ^s   Pedetti, Mariano ^u   D'Amore, Antonio ^v   Nigro, Carmine ^w   Buttazzo, Roberto ^x   Taranto, Antonello ^y   Magnelli, Fernanda ^z   Faillace, Guido ^aa   Ferdico, Michele ^ab   Montesano, Franco ^ac   more..

^a POLICLINICO UMBERTO I   (Italy)

^b AUSL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f Drug Addiction and Alcoholism Prevention and Treatment   (Italy)

^g Gastroenterology and Hepatology Unit   (Italy)

^h Azienda USL di Bologna   (Italy)

ⁱ ASS 1   (Italy)

^j ASL 2   (Italy)

^k ASL   (Italy)

^l ASL   (Italy)

^m ASL 2   (Italy)

ⁿ ASL   (Italy)

^o APSS   (Italy)

^p Direzione Sanitaria   (Italy)

^q ASL   (Italy)

^r ASL   (Italy)

^s ASL   (Italy)

^t USL 5   (Italy)

^u Laboratorio Analisi   (Italy)

^v ASL 2   (Italy)

^w ASL 3   (Italy)

^x ASL Lecce   (Italy)

^y ASL   (Italy)

^z ASP   (Italy)

^aa ASL 9   (Italy)

^ab ASL 1   (Italy)

^ac CT ASP   (Italy)

more..

Author keywords

HCV

Indexed keywords

ANTIVIRUS AGENT; CANNABIS; COCAINE; DIAMORPHINE; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL EVALUATION; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTOR VARIABLE; PREVALENCE; SAMPLE;

ADOLESCENT; ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RNA, VIRAL; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84865565157     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23370     Document Type: Article

References (12)

1. Almasio PL, Babudieri S, Barbarini G, Brunetto M, Conte D, Dentico P, Gaeta GB, Leonardi C, Levrero M, Mazzotta F, Morrone A, Nosotti L, Prati D, Rapicetta M, Sagnelli E, Scotto G, Starnini G. 2011. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liver Dis 43:589-595.
2. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L. 2008. Changing HCV genotypes distribution in Poland-Relation to source and time of infection. J Clin Virol 42:156-159.
3. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition-Text Revision (DSMIV-TR). Washington, DC: American Psychiatric Association (Pub.), 2000.
4. European Association for the Study of the Liver. 2011. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol 55:245-264.
5. Kleinbaum DG, Kupper LL, Chambless LE. 1982. Logistic regression analysis of epidemiologic data: Theory and practice. Commun Stat 11:485-547.
6. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. 2011. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet 378:571-583.
7. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coudé M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourlière M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrère JJ, Lunel-Fabiani F. 2005. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat 12:405-413.
8. Quaglio GL, Lugoboni F, Pajusco B, Sarti M, Talamini G, Mezzelani P, Des Jarlais DC, GICS. 2003. Hepatitis C virus infection: Prevalence, predictor variables and prevention opportunities among drug users in Italy. J Viral Hepat 10:394-400.
9. Schröter M, Zöllner B, Schäfer P, Reimer A, Müller M, Laufs R, Feucht HH. 2002. Epidemiological dynamics of hepatitis C virus among 747 German individuals: New subtypes on the advance. J Clin Microbiol 40:1866-1868.
10. Sereno S, Perinelli P, Laghi V. 2009. Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-Relation to period of injection started. J Clin Virol 45:354-357.
11. Stroffolini T, Fiume A, Fatale G, Regni F, Ciccozzi M, Marzolini A, Mele A. 1997. Hepatitis C virus genotypes among intravenous drug users in Italy. Hepatol Res 9:20-27.
12. Khattab MA, Ferenci P, Hadziyannis SJ, Colombo M, Manns MP, Almasio PL, Esteban R, Abdo AA, Harrison SA, Ibrahim N, Cacoub P, Eslam M, Lee SS. 2011. Management of hepatitis C virus genotype 4: Recommendations of an International Expert Panel. J Hepatol 54:1250-1262.